Delivery Order SPE2DB25D3108-SPE2DB25FPDBL

Award Date 6/10/25
Potential Completion Date 6/11/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,144.20, is for the delivery of JANUVIA 50 MG TABLET 90S, a prescription medication used to treat type 2 diabetes. The contract is a firm fixed-price delivery order with a performance period ending on March 18, 2025. This contract is not designated as a set-aside and is part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUVIA 50 MG tablets, a medication used to treat type 2 diabetes. The contract has a ceiling value of $6,366.85 and a period of performance through April 1, 2025. It is a firm fixed-price contract, and there is no set-aside designation indicated. AmerisourceBergen holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of JANUVIA 50 MG TABLET 90S, a medication used to treat diabetes. The contract has a total ceiling value of $6,181.67 and an ultimate completion date of July 3, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,577.21, is for the supply of JANUVIA 50 MG TABLET 90S, a medication used in the treatment of diabetes. The contract has an ultimate completion date of January 28, 2025, and is a Firm Fixed Price contract. This order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of JANUVIA 100 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has a firm fixed price of $2,792.76 and a completion date of May 21, 2025. This contract is not set aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $3,544.45 firm fixed-price contract is for the supply of JANUVIA 100 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of May 30, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 50 mg tablets, a diabetes medication, with a ceiling value of $1,109.94 and a performance period ending on April 18, 2025. The contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Januvia 100 mg tablets, a prescription medication used to treat type 2 diabetes. The contract has a firm fixed price of $1,455.28 and a period of performance through April 30, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Januvia 50 mg tablets, a medication used to treat type 2 diabetes. The contract has a firm fixed-price pricing type, a ceiling value of $1,128.42, and a completion date of June 13, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,502.24, is for the delivery of JANUVIA 100 MG TABLET 90S, a pharmaceutical product used in the treatment of diabetes. The contract is a firm fixed-price delivery order with a completion date of January 17, 2025. The contract has no set-aside designation, indicating open competition....
  • SPE2DB25D3108
    Indefinite Delivery Contract
  • SPE2DB25D3108-SPE2DB25FPDBL
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUVIA 50 MG TABLET 90S, a medication used to treat type 2 diabetes. The contract has a firm fixed price of $1,455.28 and a period of performance ending on June 11, 2025. The contract is not set-aside and was awarded on June 10, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order contract supports the DLA's mission to provide medical supplies and pharmaceuticals to the U.S. military and other government agencies.

Generated 9/9/25, 12:52 PM